NCT06364982 Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease.
| NCT ID | NCT06364982 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitat Internacional de Catalunya |
| Condition | Peri-implant Mucositis |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-04-05 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2024-04-05 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to analyse contiguous dental implants and its peri-implant status depending on different inter-implant distances.
Eligibility Criteria
Inclusion Criteria: * The patient must be ≥18 years of age and systemically healthy; * Partially edentulous patients, rehabilitated until 2020 (i.e., a minimum of 3 years of function time) with at least two contiguous implant-supported restorations in the maxilla or mandible; * Screw or cemented-retained prosthesis; * Fixed dental prosthesis (i.e., single crowns and partial prosthesis); * No implant mobility. Exclusion Criteria: * Pregnant and lactating women; * Patients who have taken systemic antibiotics during the 3 months prior to the examination; * Patients being treated with drugs that may induce a gingival overgrowth; * Patients undergoing orthodontic treatment (since it can influence periodontal diagnosis); * Patients who have received mechanical debridement during the 3 months prior to the exam; * Patients who have received surgical treatment for peri-implantitis; * Psychophysical inability to carry out study procedures.
Contact & Investigator
Cristina V Vallès, PhD
STUDY DIRECTOR
Department of Periodontology, University Internacional de Cataluña
Frequently Asked Questions
Who can join the NCT06364982 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Peri-implant Mucositis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06364982 currently recruiting?
Yes, NCT06364982 is actively recruiting participants. Contact the research team at ioannisterpou.95@uic.es for enrollment information.
Where is the NCT06364982 trial being conducted?
This trial is being conducted at Sant Cugat del Vallès, Spain.
Who is sponsoring the NCT06364982 clinical trial?
NCT06364982 is sponsored by Universitat Internacional de Catalunya. The principal investigator is Cristina V Vallès, PhD at Department of Periodontology, University Internacional de Cataluña. The trial plans to enroll 180 participants.